Dr. Eric Omar Then, MD

Dr. Then practices at AdventHealth DeLand in Deland, Florida, part of AdventHealth.

Dr. Then's NPI, 1336677798, was assigned on May 30, 2017. Dr. Then graduated from Universidad Iberoamericana (UNIBE) in 2015. Dr. Then's Massachusetts license number on file is 1013320.

Dr. Then's primary practice is AdventHealth DeLand, at 701 W Plymouth Ave, Deland, FL 32720 in Volusia County. The practice phone is (386) 943-4522.

Dr. Then's primary practice is AdventHealth DeLand in Deland, Florida, part of AdventHealth. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Then to 1 more behavioral health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Then practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Then's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Then is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Then's licenses on file in 3 states: Massachusetts, Florida and New York.

Dmand AI lists colonoscopy, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Then treats.

CMS data shows 172 Medicare services from Dr. Then across 8 procedure codes in 2024, for 155 Medicare patients. Medicare paid $11,903 for them.

CMS counts 155 Medicare patients who saw Dr. Then in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Then's median patient age at 72, with 59% women.

In 2024, Dr. Then wrote 68 Medicare Part D claims for 61 patients. 90% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $601 in total drug cost. In 2023, CMS named 133 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Then for performance year 2024, reported through an alternative payment model (APM). Dr. Then accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 139 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Then, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 40 papers to Dr. Then, published from 2018 to 2024. 2019 was the busiest year, with 12. The most frequent topics are Adenocarcinoma, Colitis, Ischemic and Gastrointestinal Hemorrhage. Dr. Then has published most often in Cureus. Dr. Then's most frequent co-authors are Tagore Sunkara, MD, Andrea N. Culliford, MD and Febin John, MD.

CMS Open Payments shows 63 general payments to Dr. Then from 10 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $911.

Dmand AI lists 1 award for Dr. Then, most recently Fellow of the year award in 2023.

Dr. Then graduated from Universidad Iberoamericana (UNIBE) in 2015. Dr. Then is a member of ACG, ACP, AGA and ASGE.

Dr. Then is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.